Results 161 to 170 of about 3,380,570 (289)

A high-throughput, fully automated competition assay to evaluate SARS-CoV-2 neutralizing responses and epitope specificity in clinical samples. [PDF]

open access: yesSci Rep
Atarashi Y   +11 more
europepmc   +1 more source

Preclinical Development of SGN-CD47M: Protease-Activated Antibody Technology Enables Selective Tumor Targeting of the Innate Immune Checkpoint Receptor CD47. [PDF]

open access: yesMol Cancer Ther
Levengood MR   +19 more
europepmc   +1 more source

Response by Antibodies to Tissue Antigens in the Course of Rheumatic Fever

open access: bronze, 1956
V. Wagner   +5 more
openalex   +1 more source

Data-driven evaluation of suitable immunogens for improved antibody selection. [PDF]

open access: yesProtein Sci
Waury K   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy